Health Affairs  |  September 13, 2023

Read the Publication

As we have covered in previous articles here, the new authority Congress provided to the Department of Health and Human Services (HHS) under the Inflation Reduction Act (IRA) to directly negotiate the price Medicare pays for a few high-cost drugs is facing a concerted legal attack by drug manufacturers and their allies.

Read more here.

Related Initiatives

Health Policy and the Law

Latest publications See All